Search Results

Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.

Colossal Biosciences, the world’s first de-extinction company, announces that their Woolly Mammoth team has achieved a global-first iPSC breakthrough.

Colossal Biosciences, the breakthrough genetic engineering and de-extinction company, is pleased to announce the formation of the Tasmania Thylacine Advisory Committee.

Colossal Biosciences, the world’s first de-extinction company, and BioRescue, a consortium initiating and leading the scientific rescue mission of the northern white rhino employing advanced assisted reproduction technologies and stem cell associated techniques, have teamed up to save the northern white rhino from extinction.

Colossal today announces progress on its ancient DNA agenda and a go-forward vision to enable critical new discoveries from ancient DNA through its academic partners that may prove invaluable to how we navigate our changing climate.

Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project, which aims to sequence high-quality reference genomes for all living vertebrates, partnered to successfully generate the first high-quality reference genome of the African elephant.

Tuesday, de-extinction company Colossal Biosciences closed a mammoth, $150 million Series B financing round and announced plans to resurrect the iconic Dodo – extinct since the 17th century.

Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, BOLD Capital, and Jazz Ventures, among others.